As‐Needed Inhaled Corticosteroid‐Formoterol in a Single Inhaler Compared to Inhaled Corticosteroid‐Albuterol in Separate Inhalers as Reliever Therapy in Mild Pediatric Asthma: A Cost‐Utility Analysis
Compared with the use of as-needed ICS-albuterol in separate inhalers, the use of ICS-formoterol in a single inhaler as reliever therapy is cost-effective in patients aged 12 years or more with mild asthma, because it showed a greater gain in QALYs at lower total treatment costs.
Authors
- Carlos E. Rodríguez‐Martínez (ORCID: https://orcid.org/0000-0003-2560-6693)
- Mónica P. Sossa‐Briceño
- Jefferson Antonio Buendía (ORCID: https://orcid.org/0000-0003-2404-6612)
Institutions
- Universidad El Bosque (CO)
- Universidad de Antioquia (CO)
- Universidad Nacional de Colombia (CO)
Publication Details
- Journal
- Pediatric Pulmonology
- Published
- 2024-12-31
- DOI
- https://doi.org/10.1002/ppul.27466
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00